Associations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: A prospective cohort study.

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1995) 57.68

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation (2009) 35.24

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol (1992) 13.63

Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25

Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci (2002) 6.82

Manual for scoring socioeconomic status for research on health behavior. Public Health Rep (1970) 6.31

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology (2004) 4.67

[Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi (2007) 3.82

The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol (1993) 3.66

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int (1999) 3.18

Physical Activity Scale for the Elderly (PASE): the relationship with activity measured by a portable accelerometer. J Sports Med Phys Fitness (1999) 2.97

A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol (2006) 2.74

Urologic diseases in america project: benign prostatic hyperplasia. J Urol (2008) 2.38

A comprehensive definition for metabolic syndrome. Dis Model Mech (2009) 2.23

Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol (2003) 2.17

The correlation between metabolic syndrome and prostatic diseases. Eur Urol (2011) 1.83

Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol (2011) 1.81

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology (1999) 1.81

Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol (2007) 1.76

Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int (2014) 1.73

Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009. Prev Med (2013) 1.51

Association of metabolic syndrome and benign prostatic hyperplasia in Chinese patients of different age decades. Urol Int (2013) 1.44

High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med (1998) 1.32

Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers (2006) 1.24

Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Eur Urol (1997) 1.19

Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients. World J Urol (2015) 1.16

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis (2012) 1.14

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. J Endocrinol (2012) 1.13

Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest (2014) 1.12

Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int (2000) 1.10

Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol (2013) 1.04

Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study. J Urol (2011) 1.01

Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. J Urol (2008) 1.01

Transabdominal ultrasound in the evaluation of prostate size. J Clin Ultrasound (1982) 0.99

Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention. Korean J Urol (2011) 0.98

Guideline for the primary care management of male lower urinary tract symptoms. BJU Int (2004) 0.97

The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome. Urology (2013) 0.97

A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms. J Urol (2013) 0.96

Obesity and benign prostatic enlargement: a large observational study in China. Urology (2007) 0.92

Association between metabolic syndrome and male lower urinary tract symptoms in Japanese subjects using three sets of criteria for metabolic syndrome and International Prostate Symptom Score. Urology (2011) 0.90

Suprapubic transvesical sonography of the prostate: determination of prostate size. Eur Urol (1983) 0.90

Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male (2009) 0.86

Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia. Ann N Y Acad Sci (2010) 0.85

Metabolic syndrome and accompanying hyperinsulinemia have favorable effects on lower urinary tract symptoms in a generally healthy screened population. J Urol (2011) 0.85

Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms. Urology (2014) 0.84

Association of metabolic syndrome and benign prostate enlargement in young korean males. Korean J Urol (2011) 0.84

Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol (2016) 0.84

Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort. Urology (2013) 0.82

Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study. BJU Int (2015) 0.81

Lower likelihood of having moderate-to-severe lower urinary tract symptoms in middle-aged healthy Korean men with metabolic syndrome. Urology (2014) 0.79

Analysis of suprapubic and transrectal measurements in assessment of prostate dimensions and volume: is transrectal ultrasonography really necessary for prostate measurements? Urol J (2009) 0.79

Transverse prostate measurement obtained using transabdominal ultrasound: possible role in transurethral needle ablation of the prostate. Urology (2000) 0.76

The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome. Urol Int (2016) 0.76

Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms. Urol J (2016) 0.76

The whirlpool sign: midgut volvulus. Emerg Med J (2014) 0.75

Rupture of renal artery aneurysm: a rare urologic emergency entity. Urology (2014) 0.75